Presentation TCT 2012 TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder Presenter: Ignacio Cruz-Gonz?lez October 23, 2012
Presentation TCT 2012 PFO Closure for Migraine: Predictors of Clinical Improvement Following PFO Closure Presenter: Brian Whisenant October 22, 2012
Presentation TCT 2012 Making PFO Closure the Lowest Risk Interventional Procedure: Devices and Techniques Presenter: Horst Sievert October 22, 2012
Presentation TCT 2012 Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? NO Presenter: John Carroll October 22, 2012
Presentation TCT 2012 Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES Presenter: Ted Feldman October 22, 2012
Presentation TCT 2012 ASD Closure: The European Perspectives Presenter: Horst Sievert October 22, 2012
Presentation TCT 2012 ASD Closure: Current Techniques, Avoiding Erosion, and the Role of Surgery Presenter: Ziyad Hijazi October 22, 2012
News Industry News FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study October 22, 2012
News Industry News First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect October 19, 2012
News Daily News Survey Reflects US Structural Intervention Training in Its ‘Infancy’ Jason Kahn July 31, 2012
News Daily News Un Meta Análisis asegura que el Cierre del FOP para Prevenir ACV es Ventajoso July 17, 2012
Presentation Meta-Analysis of Transcatheter Closure vs. Medical Therapy for PFO in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism Presenter: 164856|Shikhar Agarwal; July 16, 2012
Presentation Effect of Patent Foramen Ovale Closure on Visual Aura Without Headache or Typical Aura with Migraine Headache Presenter: H. Khessali June 18, 2012